Market Overview

Jefferies Initiates Axovant Sciences At Buy


Jefferies initiated coverage on Axovant Sciences Ltd (NYSE: AXON) with a Buy rating.

The target price for Axovant Sciences is set to $31.

Axovant Sciences' shares climbed 5.21 percent to $20.19 in after-hours trading.

Latest Ratings for AXON

Dec 2018UpgradesHoldBuy
Jan 2018DowngradesOutperformMarket Perform
Jan 2018UpgradesSellNeutral

View More Analyst Ratings for AXON
View the Latest Analyst Ratings

Posted-In: JefferiesInitiation Analyst Ratings


Related Articles (AXON)

View Comments and Join the Discussion!

Latest Ratings

PNRJefferiesInitiates Coverage On
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Ferrellgas Acquires Utah's Propane Advantage

Stifel Nicolaus Initiates Biotie Therapies At Buy